Journal of International Obstetrics and Gynecology ›› 2017, Vol. 44 ›› Issue (2): 228-231.

Previous Articles     Next Articles

Research Progress of Anti-Mullerian Hormone Levels in Patients with Endometriosis

DONG Zhen-zhu,XIE Xi,MAO Xiao-dan,SUN Peng-ming   

  1. Fujian Provincial Maternity and Children′s Health Hospital of Fujian Medical University,Fuzhou 350001,China
  • Received:2017-01-10 Revised:2017-03-04 Published:2017-04-15 Online:2017-05-18
  • Contact: SUN Peng-ming,E-mail:sunfemy@hotmail.com E-mail:471343401@qq.com

Abstract: 【Abstract】  Endometriosis (EMs) is a common disease in women of reproductive age, including three types: peritoneal type, deep-infiltration type and ovarian type. EMs is estimated to affect around 2% of reproductive period women. Ovarian endometriomas are presented in 40% of women with endometriosis, of which 40%-50% are infertility and have the characteristics of a high relapse rate. The therapy includes drugs and surgery. In recent years, studies have reported the cystectomy of ovarian endometrioma may cause the decline of ovarian reserve and even premature ovarian failure, but endometriosis itself, especially the effect of ovarian endometriosis on ovarian reserve is rarely reported. Anti-Mullerian hormone (AMH) is a reliable marker of ovarian reserve in recent years. By analyzing the the AMH basal level in different types of endometriosis to evaluate the effect of endometriosis on ovarian reserve, so as to guide the clinical work.

Key words: 【Keywords】 , Endometriosis, Anti-Mullerian hormone, Ovarian reserve